FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153095847> ?p ?o ?g. }

• W2153095847 endingPage "5176" @default.
• W2153095847 startingPage "5168" @default.
• W2153095847 abstract "Abstract AU-rich element-binding proteins (ARE-BP) regulate the stability and/or translational efficiency of mRNAs containing cognate binding sites. Many targeted transcripts encode factors that control processes such as cell division, apoptosis, and angiogenesis, suggesting that dysregulated ARE-BP expression could dramatically influence oncogenic phenotypes. Using several approaches, we evaluated the expression of four well-characterized ARE-BPs across a variety of human neoplastic syndromes. AUF1, TIA-1, and HuR mRNAs were not systematically dysregulated in cancers; however, tristetraprolin mRNA levels were significantly decreased across many tumor types, including advanced cancers of the breast and prostate. Restoring tristetraprolin expression in an aggressive tumor cell line suppressed three key tumorgenic phenotypes: cell proliferation, resistance to proapoptotic stimuli, and expression of vascular endothelial growth factor mRNA. However, the cellular consequences of tristetraprolin expression varied across different cell models. Analyses of gene array data sets revealed that suppression of tristetraprolin expression is a negative prognostic indicator in breast cancer, because patients with low tumor tristetraprolin mRNA levels were more likely to present increased pathologic tumor grade, vascular endothelial growth factor expression, and mortality from recurrent disease. Collectively, these data establish that tristetraprolin expression is frequently suppressed in human cancers, which in turn can alter tumorigenic phenotypes that influence patient outcomes. [Cancer Res 2009;69(12):5168–76]" @default.
• W2153095847 created "2016-06-24" @default.
• W2153095847 creator A5006990099 @default.
• W2153095847 creator A5013949980 @default.
• W2153095847 creator A5014511510 @default.
• W2153095847 creator A5033396908 @default.
• W2153095847 creator A5044404083 @default.
• W2153095847 creator A5080416441 @default.
• W2153095847 date "2009-06-15" @default.
• W2153095847 modified "2023-10-18" @default.
• W2153095847 title "The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis" @default.
• W2153095847 cites W1605365699 @default.
• W2153095847 cites W1607267312 @default.
• W2153095847 cites W1964072966 @default.
• W2153095847 cites W1972739162 @default.
• W2153095847 cites W1985656356 @default.
• W2153095847 cites W1992166423 @default.
• W2153095847 cites W1992360356 @default.
• W2153095847 cites W2003287029 @default.
• W2153095847 cites W2010871781 @default.
• W2153095847 cites W2012879636 @default.
• W2153095847 cites W2016776106 @default.
• W2153095847 cites W2029706883 @default.
• W2153095847 cites W2034269086 @default.
• W2153095847 cites W2043497955 @default.
• W2153095847 cites W2054038109 @default.
• W2153095847 cites W2061202161 @default.
• W2153095847 cites W2068054277 @default.
• W2153095847 cites W2069727672 @default.
• W2153095847 cites W2076510291 @default.
• W2153095847 cites W2082668371 @default.
• W2153095847 cites W2088290283 @default.
• W2153095847 cites W2088714384 @default.
• W2153095847 cites W2102606027 @default.
• W2153095847 cites W2108426942 @default.
• W2153095847 cites W2113576489 @default.
• W2153095847 cites W2115282694 @default.
• W2153095847 cites W2116508133 @default.
• W2153095847 cites W2125043493 @default.
• W2153095847 cites W2134496526 @default.
• W2153095847 cites W2137473909 @default.
• W2153095847 cites W2139437132 @default.
• W2153095847 cites W2145285946 @default.
• W2153095847 cites W2149665972 @default.
• W2153095847 cites W2152745012 @default.
• W2153095847 cites W2155633497 @default.
• W2153095847 cites W2159376549 @default.
• W2153095847 cites W2318133697 @default.
• W2153095847 doi "https://doi.org/10.1158/0008-5472.can-08-4238" @default.
• W2153095847 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2724875" @default.
• W2153095847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19491267" @default.
• W2153095847 hasPublicationYear "2009" @default.
• W2153095847 type Work @default.
• W2153095847 sameAs 2153095847 @default.
• W2153095847 citedByCount "182" @default.
• W2153095847 countsByYear W21530958472012 @default.
• W2153095847 countsByYear W21530958472013 @default.
• W2153095847 countsByYear W21530958472014 @default.
• W2153095847 countsByYear W21530958472015 @default.
• W2153095847 countsByYear W21530958472016 @default.
• W2153095847 countsByYear W21530958472017 @default.
• W2153095847 countsByYear W21530958472018 @default.
• W2153095847 countsByYear W21530958472019 @default.
• W2153095847 countsByYear W21530958472020 @default.
• W2153095847 countsByYear W21530958472021 @default.
• W2153095847 countsByYear W21530958472022 @default.
• W2153095847 countsByYear W21530958472023 @default.
• W2153095847 crossrefType "journal-article" @default.
• W2153095847 hasAuthorship W2153095847A5006990099 @default.
• W2153095847 hasAuthorship W2153095847A5013949980 @default.
• W2153095847 hasAuthorship W2153095847A5014511510 @default.
• W2153095847 hasAuthorship W2153095847A5033396908 @default.
• W2153095847 hasAuthorship W2153095847A5044404083 @default.
• W2153095847 hasAuthorship W2153095847A5080416441 @default.
• W2153095847 hasBestOaLocation W21530958471 @default.
• W2153095847 hasConcept C104317684 @default.
• W2153095847 hasConcept C105580179 @default.
• W2153095847 hasConcept C121608353 @default.
• W2153095847 hasConcept C127716648 @default.
• W2153095847 hasConcept C2780394083 @default.
• W2153095847 hasConcept C2909367411 @default.
• W2153095847 hasConcept C41282012 @default.
• W2153095847 hasConcept C502942594 @default.
• W2153095847 hasConcept C54355233 @default.
• W2153095847 hasConcept C71924100 @default.
• W2153095847 hasConcept C86803240 @default.
• W2153095847 hasConceptScore W2153095847C104317684 @default.
• W2153095847 hasConceptScore W2153095847C105580179 @default.
• W2153095847 hasConceptScore W2153095847C121608353 @default.
• W2153095847 hasConceptScore W2153095847C127716648 @default.
• W2153095847 hasConceptScore W2153095847C2780394083 @default.
• W2153095847 hasConceptScore W2153095847C2909367411 @default.
• W2153095847 hasConceptScore W2153095847C41282012 @default.
• W2153095847 hasConceptScore W2153095847C502942594 @default.
• W2153095847 hasConceptScore W2153095847C54355233 @default.
• W2153095847 hasConceptScore W2153095847C71924100 @default.
• W2153095847 hasConceptScore W2153095847C86803240 @default.
• W2153095847 hasIssue "12" @default.

• next